Education
About Us
Working with TipRanks
Follow Us
Thomas B Smith Insider Profile
4 Followers
Thomas B Smith, CMO at BioDelivery, holds 70.26K shares in Collegium Pharmaceutical (Ticker: COLL), holds 0.00 shares in BioDelivery (Ticker: BDSI). Most recently, Thomas B Smith Sold ― shares of Collegium Pharmaceutical on Sep 03, 2025 for an estimated value of $671.50K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+12.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP and Chief Medical Officer
Roles that Thomas B Smith holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 04, 2024 - Mar 04, 2025
Return:+24.20%
The most profitable trade made by Thomas B Smith
Thomas B Smith's Trading History
BioDelivery
Mar 22, 2022
―
Uninformative Sell
―
$0.00
Collegium Pharmaceutical
Sep 03, 2025
EVP and Chief Medical Officer
Informative Sell
671.50K
$2.42M
List of latest transactions for each holding click on a transaction to see Thomas B Smith's performance on stock
You May Also Like
Thomas B Smith insider profile FAQ
What is the percentage of profitable transactions made by Thomas B Smith?
The percentage of profitable transactions made by Thomas B Smith is 100%.
What is the average return per transaction made by Thomas B Smith?
The average return per transaction made by Thomas B Smith is 12.90%.
What stocks does Thomas B Smith hold?
Thomas B Smith holds: BDSI, COLL stocks.
What was Thomas B Smith’s latest transaction?
Thomas B Smith latest transaction was an Informative Sell of $671.50K.
What was Thomas B Smith's most profitable transaction?
Thomas B Smith’s most profitable transaction was an Informative Sell of COLL stock on March 4, 2024. The return on the trade was 24.20%.
What is Thomas B Smith's role in BioDelivery?
Thomas B Smith's role in BioDelivery is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.